Products

What will AGI do for Actisomide?

This classification denotes an antiarrhythmic agent with the molecular formula C23H35N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) IJQ29N87NR, chemically known as 3h-pyrido(1,2-c)pyrimidin-3-one, 4-(2-(bis(1-methylethyl)amino)ethyl)-4,4a,5,6,7,8-hexahydro-1-methyl-4-phenyl-, cis-(+-)- but more generally known as actisomide, which bears US NIH Compound Identifier 57147. European Medicines Agency schedules Actisomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05257MIG. The term ACTISOMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). ACTISOMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule actisomide under HS 29335995 and SITC 51576. As of Q4 2014, ACTISOMIDE remains US FDA's Preferred Term for this commodity. Actisomide bears US NLM identifiers UMLS ID C0074107 and NCI Concept Code C90662. SMILES: O=C1N=C(N2C(C1(CCN(C(C)C)C(C)C)C1CCCCC1)CCCC2)C.